A single arm, phase 2, multicenter, international trial of tisotumab vedotin (HuMax-TF-ADC) in previously treated, recurrent or metastatic cervical cancer.

被引：1
|
作者：
Coleman, Robert L.
Concin, Nicole
Herzog, Thomas J.
Woelber, Linn Lena
Mirza, Mansoor Raza
Monk, Bradley J.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS5601
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS5601
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study
    Jiang, Kuikui
    Hong, Ruoxi
    Xia, Wen
    Lu, Qianyi
    Li, Liang
    Huang, Jianhao
    Shi, Yanxia
    Yuan, Zhongyu
    Zheng, Qiufan
    An, Xin
    Xue, Cong
    Huang, Jiajia
    Bi, Xiwen
    Chen, Meiting
    Zhang, Jingmin
    Xu, Fei
    Wang, Shusen
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 513 - 521
  • [32] Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
    Rochlitz, C.
    Ruhstaller, T.
    Lerch, S.
    Spirig, C.
    Huober, J.
    Suter, T.
    Buehlmann, M.
    Fehr, M.
    Schoenenberger, A.
    von Moos, R.
    Winterhalder, R.
    Rauch, D.
    Mueller, A.
    Mannhart-Harms, M.
    Herrmann, R.
    Cliffe, B.
    Mayer, M.
    Zaman, K.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 80 - 85
  • [33] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
    Xu, Jianming
    Bai, Yuxian
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    CANCER, 2021, 127 (21) : 3975 - 3984
  • [34] Toripalimab combined with bevacizumab and chemotherapy for refractory, recurrent or metastatic cervical cancer: preliminary results of a single-arm, open-label, phase II trial
    Peng, Peng
    Yao, Hairong
    Liu, Dantong
    He, Yonglan
    Liu, Shikai
    Xiang, Yang
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S29 - S29
  • [35] Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial*
    Adkins, Douglas
    Ley, Jessica
    Atiq, Omar
    Powell, Steven
    Spanos, William C.
    Gitau, Mark
    Rigden, Caron
    Palka, Kevin
    Liu, Jingxia
    Oppelt, Peter
    ORAL ONCOLOGY, 2021, 115
  • [36] Efficacy and safety of cadonilimab plus lenvatinib in previously immunotherapy treated advanced/metastatic clear cell renal cell carcinoma (ccRCC): A multicenter, single-arm, phase II trial
    Huang, J.
    Zhao, J.
    Hu, X.
    Kong, W.
    Chen, Q.
    Zhang, J.
    Chen, Y.
    Guo, J.
    Xu, D.
    Xue, W.
    ANNALS OF ONCOLOGY, 2024, 35 : S1512 - S1512
  • [37] Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
    Wu, X.
    Xia, L.
    Wang, J.
    Wang, C.
    Zhang, Q.
    Zhu, J.
    Rao, Q.
    Cheng, H.
    Liu, Z.
    Yin, Y.
    Ai, X.
    Gulina, K.
    Zheng, H.
    Luo, X.
    Chang, B.
    Li, L.
    Liu, H.
    Li, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [38] EFFICACY AND SAFETY OF ZIMBERELIMAB (GLS-010) MONOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II STUDY
    Wu, Xiaohua
    Xia, Lingfang
    Wang, Jing
    Wang, Chunyan
    Zhang, Qingming
    Zhu, Jianqing
    Rao, Qunxian
    Cheng, Huijun
    Liu, Zheng
    Yin, Yongmei
    Ai, Xiaohong
    Gulina, Kurban
    Zheng, Hong
    Luo, Xiaoyong
    Chang, Baoping
    Li, Li
    Liu, Haiyan
    Li, Yunxia
    Lou, Ge
    Zhou, Qi
    Zhu, Yanling
    Xiao, Zemin
    Tong, Jiandong
    Wang, Ke
    Chen, Jie
    Wang, Xia
    Song, Lijie
    Wei, Zhixia
    Ye, Yijing
    Zhu, Jiman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A703 - A703
  • [39] A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy
    Li, J.
    Mao, W.
    Li, F.
    Ran, L.
    Chang, J.
    Mei, F.
    Hu, L.
    Du, Y.
    Tian, X.
    Liu, M.
    Chen, Y.
    Shan, L.
    Mu, J.
    Yin, S.
    Qin, Y.
    Liang, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E616 - E617
  • [40] A single-arm, phase II trial assessing the combination of AK105 and anlotinib in first-line treatment for persistent, recurrent, or metastatic cervical cancer
    Guo, Ruixia
    Qiu, Haifeng
    Wang, Qian
    Su, Ke
    Chang, Lei
    Cai, Mingbo
    Mao, Meng
    Bian, Aiping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345